Ana R. Goncalves
Geneve, GE 1205, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Seasonal and inter-seasonal RSV activity in the European Region during the COVID-19 pandemic from autumn 2020 to summer 2022.
Journal: Influenza and other respiratory viruses
Published: June 28, 2023
Swiss public health measures associated with reduced SARS-CoV-2 transmission using genome data.
Journal: Science translational medicine
Published: November 08, 2022
Prevalence of Immunoglobulin G (IgG) Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Evaluation of a Rapid MEDsan IgG Test in Children Seeking Medical Care.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: September 25, 2020
Molecular pathway of influenza pan-neuraminidase inhibitor resistance in an immunocompromised patient.
Journal: Antiviral therapy
Published: December 12, 2019
An Online Influenza Surveillance System for Primary Care Workers in Switzerland: Observational Prospective Pilot Study.
Journal: JMIR public health and surveillance
Published: November 28, 2019
Antigen Extraction and B Cell Activation Enable Identification of Rare Membrane Antigen Specific Human B Cells.
Journal: Frontiers in immunology
Published: December 21, 2018
Influenza A Virus Genetic Tools: From Clinical Sample to Molecular Clone.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: August 29, 2018
Comparative analysis of viral shedding in pediatric and adult subjects with central nervous system-associated enterovirus infections from 2013 to 2015 in Switzerland.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: October 21, 2016
Hospital surveillance of influenza strains: a concordant image of viruses identified by the Swiss Sentinel system?
Journal: Influenza and other respiratory viruses
Published: July 16, 2016
The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial.
Journal: The Lancet. Infectious diseases
Published: June 01, 2015
Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe.
Journal: The New England journal of medicine
Published: April 02, 2015
Showing 1-11 of 11
Last Updated: 09/26/2026